Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders

Murtaza S Nagree, Tania C Felizardo, Mary L Faber, Jitka Rybova, C Anthony Rupar, S Ronan Foley, Maria Fuller, Daniel H Fowler, Jeffrey A Medin

Open source

DOI
10.15252/emmm.202114297
Published
2022-03-17
Container
EMBO Molecular Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15252/emmm.202114297,
  title = {Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders},
  author = {Murtaza S Nagree and Tania C Felizardo and Mary L Faber and Jitka Rybova and C Anthony Rupar and S Ronan Foley and Maria Fuller and Daniel H Fowler and Jeffrey A Medin},
  year = {2022},
  journal = {EMBO Molecular Medicine},
  doi = {10.15252/emmm.202114297},
  url = {https://doi.org/10.15252/emmm.202114297}
}

RIS

TY  - JOUR
TI  - Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
AU  - Murtaza S Nagree
AU  - Tania C Felizardo
AU  - Mary L Faber
AU  - Jitka Rybova
AU  - C Anthony Rupar
AU  - S Ronan Foley
AU  - Maria Fuller
AU  - Daniel H Fowler
AU  - Jeffrey A Medin
PY  - 2022
JO  - EMBO Molecular Medicine
DO  - 10.15252/emmm.202114297
UR  - https://doi.org/10.15252/emmm.202114297
ER  - 

APA

Nagree, M. S., Felizardo, T. C., Faber, M. L., Rybova, J., Rupar, C. A., Foley, S. R., Fuller, M., Fowler, D. H., & Medin, J. A. (2022). Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202114297

Source records